Results 31 to 40 of about 31,245 (265)
Asking the 5 W's for designing next‐generation bioprocessing
AIChE Journal, EarlyView.Abstract Biotechnology is expanding beyond traditional, centralized fermentation and toward next‐generation bioprocessing paradigms that emphasize flexible deployment outside the laboratory with application‐specific performance. However, many bioprocesses fail to translate beyond proof‐of‐concept into industrially viable systems because early design ...
Sangdo Yook +4 more
wiley +1 more source
Pharmaceutical market in the Republic of Croatia [PDF]
Medicinski Glasnik, 2008 Most European health systems are currently undergoing reforms.According to the World Health Organization, the aim of the healthsystem reforms are health gains, and one of the issues brought tothe foreground with respect to this is cost-containment ...
Jerko Glavaš, Maja Lamza – Maronić
doaj
Determinants of real stock return of pharmaceutical products and materials companies
Social Determinants of Health, 2023 Background: The present study aimed to investigate the factors that determine the actual efficiency of pharmaceutical companies. Methods: This study was an applied and descriptive-correlation research.
Hojjatollah Marzban +2 more
doaj +1 more source
Evolution of Physical Intelligence Across Scales
Advanced Intelligent Discovery, EarlyView.By following the evolution of physical intelligence across scales, this article shows how intelligence arises from materials, structures, physical interactions, and collectives. It establishes physical intelligence as the evolutionary foundation upon which embodied intelligence is built.
Ke Liu +7 more
wiley +1 more source
Advanced Intelligent Discovery, EarlyView.This article outlines how artificial intelligence could reshape the design of next‐generation transistors as traditional scaling reaches its limits. It discusses emerging roles of machine learning across materials selection, device modeling, and fabrication processes, and highlights hierarchical reinforcement learning as a promising framework for ...
Shoubhanik Nath +4 more
wiley +1 more source
Health and Quality of Life Outcomes, 2021 Objective This study aimed to conduct a systematic review and meta-analysis to compare differences in health utilities (HUs) assessed by self and proxy respondents in children, as well as to evaluate the effects of health conditions, valuation methods ...
Mingyu Jiang +5 more
doaj +1 more source
Advanced Intelligent Systems, EarlyView.An instance‐level, model‐agnostic explanation of class differentiation is introduced through SHAP‐LCD, linking probability shifts to feature‐wise Shapley contributions. The method operates on tabular and image data and is released in a fully reproducible implementation, offering a transparent way to examine, at each instance, why predictive models ...
Roxana M. Romero Luna +2 more
wiley +1 more source
Medication reconciliation in a hospital environment: Avoided discrepancies and cost savings - A single arm intervention study: Benefits of medication reconciliation in a hospital [PDF]
Brazilian Journal of Pharmaceutical SciencesMedication reconciliation has proven to be essential for patient safety. However, studies on its economic viability are still scarce. Therefore, the aim of this study was to understand the avoided cost of medication discrepancies identified through the ...
Lays Cássia Santos Duarte +5 more
doaj +1 more source
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU).
Daniel Xiao +3 more
wiley +1 more source
The economics of alternative payment models for pharmaceuticals
The European Journal of Health Economics, 2021 Pharmaceuticals are priced uniformly by convention, but vary in their degree of effectiveness for different disease indications. As more high-cost therapies have launched, the demand for alternative payment models (APMs) has been increasing in many advanced markets, despite their well-documented limitations and challenges to implementation.
Jakub P. Hlávka +3 more
openaire +3 more sources